On April 11, 2023 MedGenome, a global precision medicine company specializing in omics solutions, reported that it will be exhibiting at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting on April 14 – 19, 2023 in Orlando, Florida (Press release, MedGenome, APR 10, 2023, View Source [SID1234629926]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling solutions. MedGenome’s advanced analyses pipeline provides researchers with a comprehensive report which includes publication ready tables, plots and detailed metrics to visualize and interpret the results. MedGenome will also exhibit its end-to-end sequencing and informatics solutions to analyze T-cell receptor (TCR) and B-cell receptor (BCR) repertoires for antibody and diagnostics marker discovery projects.

Hiranjith GH, Site Head and VP of Research Services at MedGenome and his team will be at Booth #2074. For more information, or to schedule a meeting with the MedGenome team at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting, reach out to the contact below.